Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.
about
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune ResistanceAnimal models of myasthenia gravis: utility and limitationsPaving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the FateMyeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor MicroenvironmentMyeloid suppressor cells and immune modulation in lung cancerTherapeutic cancer vaccines: past, present, and futureWays to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesMyeloid-derived suppressor cells and anti-tumor T cells: a complex relationshipThe divergent roles of macrophages in solid organ transplantationMesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumorSurgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer RecurrencePhenotype, development, and biological function of myeloid-derived suppressor cellsMyeloid cells in hepatocellular carcinomaMyeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacyMyeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedSignificant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCsOrchestration of angiogenesis by immune cellsModification of the tumor microenvironment as a novel target of renal cell carcinoma therapeuticsCoordinated regulation of myeloid cells by tumoursIL-17 mediated inflammation promotes tumor growth and progression in the skinIdentification of myeloid derived suppressor cells in dogs with naturally occurring cancerUnlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancerTargeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.Very small size proteoliposomes abrogate cross-presentation of tumor antigens by myeloid-derived suppressor cells and induce their differentiation to dendritic cellsThe receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer.Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells.Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism.IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cellsOpposing roles for complement component C5a in tumor progression and the tumor microenvironment.New roads open up for implementing immunotherapy in mesothelioma.HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cellsCannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive propertiesResistance to Streptozotocin-Induced Autoimmune Diabetes in Absence of Complement C3: Myeloid-Derived Suppressor Cells Play a Role.Myeloid-derived suppressor cells modulate immune responses independently of NADPH oxidase in the ovarian tumor microenvironment in mice.Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasLMyeloid derived suppressor cells in chronic myeloid leukemia.Progression of Large Lymphoma Is Significantly Impeded with a Combination of Gemcitabine Chemotherapy and Dendritic Cells Intra-Tumor Vaccination.
P2860
Q26746986-E8028B2F-A35A-4942-A1D0-2C041E80C6C7Q26750632-670AE21F-BCD2-4DF0-84C4-8AEE7002C7D3Q26777205-E3B7CD18-60B3-4207-9CA0-808B4CE61E87Q26799126-C5415FF9-31D6-4F53-A1E3-0F2C3F49B8C4Q26823251-CABAB0E5-A997-446A-966A-1CEBBFD5D014Q26863283-7708C59C-D480-4D21-97C2-2CDEBDCF3EF4Q26991991-286D97E9-9C17-4230-A26B-F2646AB9E489Q27000087-9E2ABD68-2444-4204-8A19-000609B91964Q27022711-B0E644F7-75ED-4DAB-93B3-C11E0DAEA8C6Q27320784-58425926-BB9A-4F08-A744-4972CD4F7C9EQ27345519-D4E40AC9-B2B6-4D61-9E44-4FE4B5B68F4FQ28079046-1AE02FC6-4D78-44B4-977B-FFE94393270EQ28081161-3D269540-8B9D-477C-AEC4-9834136E372EQ28082461-D0F70F6F-F4D2-47B3-9949-1BA3B1A7257DQ28084627-4710B655-9B5A-4C3C-AE52-699126AE4AFCQ28086980-98A6C226-F9B0-41D4-B53B-E9861A021669Q28389236-FBCAE15B-26B0-48DE-9EC5-156C2D5AD414Q28393614-C9393E2E-D2E7-4E6E-B38E-1010A9C8F986Q28395157-2970B3F6-EFB5-4135-8714-262F87481367Q28480915-6ED9EA0C-3DBA-4B18-A248-C091651A1369Q28481476-083D18DC-FA4A-4444-9403-8C9F8387C610Q28744369-D04C74B9-A9A0-4874-A639-0234612F9A34Q30413623-E27229DD-1AA3-457E-B950-6B4434B0FCAFQ33584867-244BA5B6-834B-4E08-94E8-A496C3E977CFQ33585293-68475F89-F561-43A5-A2EC-8FE5494F7E7BQ33606156-5A132977-1475-4291-94C9-0CE85CF18800Q33709243-073001CB-3FBF-42BE-963B-FB9DF1B7A59CQ33733198-134C04CB-6075-4C67-918F-2EADF4232D2EQ33980128-E87E99DE-0AAE-443E-A898-595C7163E168Q34081723-F6AF787D-82FD-4A20-A4EF-27C55DB56E9BQ34095907-B8DEC21E-0762-4894-9640-2C3AB2D0325BQ34295401-30E7FC87-EC3A-4A6D-8C18-2F70F7819F24Q34331993-5290A0F2-721C-44A2-8253-3000A4CD9FB4Q34353413-AF1AD50D-F2DC-44D5-966E-FE17E13DE3F6Q34789214-7E903D91-408D-4FED-8A48-8C1738E7085BQ34793522-C6AC3DC2-C5BD-4FFA-BB0C-B9DA87834674Q34903354-D8BC3D04-7C56-4E03-8672-D5F851EFF2A3Q35029951-240D6326-54A3-43F5-B25D-EDA7CEE8D215Q35609094-05B46AAC-5B82-4CBA-89EF-585EC5932D81Q35693324-0C28A5C1-C801-4181-A498-DD434A57AA6F
P2860
Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@ast
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@en
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@nl
type
label
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@ast
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@en
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@nl
prefLabel
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@ast
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@en
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@nl
P2093
P2860
P356
P1476
Myeloid-derived suppressor cel ...... sion on CD4+ and CD8+ T cells.
@en
P2093
Dan Ilkovitch
Erica M Hanson
Pratima Sinha
Suzanne Ostrand-Rosenberg
Virginia K Clements
P2860
P304
P356
10.4049/JIMMUNOL.0804253
P407
P577
2009-06-24T00:00:00Z